Enovis (NYSE:ENOV – Get Rating) and Xylem (NYSE:XYL – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Institutional and Insider Ownership 83.8% of Xylem shares are owned by institutional […]